Gelonghui, April 11, 丨 Rendu Biotech (688193.SH) announced that as of April 10, 2024, the company had repurchased 400,049 shares of the company's shares through centralized bidding transactions, accounting for 1.00% of the company's total share capital of 40,000,000 shares, an increase of 0.02% compared with the previous disclosure. The highest price of the repurchase transaction was 30.00 yuan/share, and the lowest price was 28.47 yuan/share. The total amount of capital paid was RMB 11,938,945.00 (excluding stamp duty and transactions) transaction costs such as commissions).